Fenretinide in Healthy Young Women at Genetic and Familial Risk

This study has been terminated.
(very low rate of patient accrual)
Sponsor:
Information provided by (Responsible Party):
European Institute of Oncology
ClinicalTrials.gov Identifier:
NCT01479192
First received: November 22, 2011
Last updated: January 21, 2016
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2024
  Estimated Primary Completion Date: December 2024 (Final data collection date for primary outcome measure)